Form 4 for CYTK CYTOKINETICS INC
Accepted 2026-03-10 00:00:00 ET · period of report 2026-03-09 · accession 0001061983-26-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-10 | 2026-03-09 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $60.72 | -2,907 | 138.6K | -2% | -$176.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-09 | S | D | 2,907 | $60.72 | 138,629 | D | — | — |